Immunova to Acquire AlphaTON Subsidiary Iox Therapeutics
Immunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
This piece explains how wash sale rules affect Dividend Etf losses, with practical strategies to stay compliant and preserve tax benefits.
20,231 articlesImmunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
Four years after their fight, questions about how money flows in celebrity deals continue to surface. This guide unpa...
Summit Funding plans large-scale layoffs as CrossCountry Mortgage advances its acquisition. About 163 employees will ...
As housing markets shift, investors wonder if Opendoor can deliver a meaningful stock reaction by 2026. This guide br...
A renewed policy debate on redistributing elon musk’s trillion raises questions about liquidity, feasibility, and the...
Waterfront properties can deliver strong returns, but they carry unique risks. This guide explains how to build solid...
Income investing blends steady cash flow with risk management. This article breaks down how a seasoned CIO approaches...
July 2026 offers a compelling setup for patient investors. Here’s my top-ranked stock for July, why it stands out, an...
The market hasn’t moved this year, leaving many investors uneasy about the next move. This guide explains what that c...
As inflation remains persistent, traders are moving away from speculative growth toward dependable income. Carvana is...
With the Fed set to act this month, a dirt-cheap stock looks attractive amid crosscurrents in the market. Here’s why ...
The retirement myth of needing a million dollars is fading. Income-focused strategies and Social Security can cover a...